Curaderm™ BEC5 has met all the necessary requirements for its registration by health authorities. The following major drug development phases and milestones have been obtained:
- Research
- Pre-clinical studies
- Investigational New Drug (IND) application
- Phase I to IV clinical trials
- Application and receipt of a New Drug application (NDA) approval
Curaderm™
The Natural Skin Cancer Treatment
CURADERM BEC5 approved by health authorities for the treatment of non melanoma skin cancers. The superior qualities of CURADERM BEC5 over other existing modalities for the treatment of skin cancers have been documented in successfully treating Basal cell and Squamous cell carcinomas as well Actinic Keratosis.
Curaderm BEC5 cream contains the active ingredient BEC which is a constant mixture of solasodine glycosides. BEC is extracted from the eggplant. It works by binding, followed by interfering with the growth of abnormal cells which are destroyed at all stages of their lifecycles. Normal cells are not affected by Curaderm BEC5. Curaderm BEC5 is a skin-use only (topical) medicine used to treat: Non melanoma skin cancers in adults.
-
Non melonama skin cancer is caused by too much sun exposure.
-
Curaderm BEC5 has not been studied in children under 18 years old for skin cancers. Children usually do not get skin cancers.
Curaderm BEC5 is a skin-use only (topical) medicine to treat certain types of non-melanoma skin cancers. The type of skin cancer needs to be diagnosed by your healthcare provider.
For more information,
testimonials and to purchase Curaderm click on the image below.
Curaderm, the only natural topical skin cancer treatment proven to successfully treat basal cell, squamous cell and actinic keratosis! Skin cancer pictures and videos of this product in action can be found by visiting the following link: skin cancer pictures